Vesugen
Moderate researchKED | Vascular Bioregulator Peptide
Vesugen is a Khavinson bioregulator tripeptide developed at Russia's St. Petersburg Institute of Bioregulation and Gerontology.
Molecular & research data
- Sequence
- Lys-Glu-Asp
- Molecular weight
- 390 Da
- Half-life
- Not established
- Routes (research)
- Oral, Injectable
- Storage
- Oral capsules: room temperature; Lyophilized powder/reconstituted: 2-8°C refrigerated
Overview
Vesugen is a Khavinson bioregulator tripeptide developed at Russia’s St. Petersburg Institute of Bioregulation and Gerontology. Composed of three amino acids (lysine, glutamic acid, aspartic acid), it targets the vascular system and protects blood vessels from age-related decline. Research shows it limits atherosclerosis development, decreases endothelial dysfunction, and activates stem cells. Like other short Khavinson peptides, Vesugen penetrates to the nucleus where it influences gene expression.
Mechanism of action
Vesugen works through epigenetic regulation by interacting with DNA promoter regions, particularly affecting Ki-67 gene expression which controls cell division. It plays a prominent role in regulating sirtuin 1 (SIRT1) protein levels - a key anti-aging protein activated during calorie restriction. Vesugen enhances mesenchymal stem cell proliferation, reduces senescence markers, improves cell differentiation, and may reverse the Senescence-Associated Secretory Phenotype (SASP) implicated in age-related cardiovascular disease.
Key research findings
- Protects vascular system from aging effects
- Limits atherosclerosis development
- Decreases endothelial cell dysfunction
- Activates SIRT1 anti-aging pathway
- Enhances stem cell proliferation
- Reduces cellular senescence markers
- Reverses SASP phenotype
- Works synergistically with Cardiogen
Research applications
Vascular Health
- Vascular Aging — Protects blood vessels from age-related deterioration through gene expression regulation.
- Atherosclerosis Prevention — Limits development of atherosclerotic plaques in blood vessels.
- Endothelial Function — Decreases endothelial dysfunction that contributes to cardiovascular disease.
Anti-Aging
- SIRT1 Activation — Regulates sirtuin 1 levels, mimicking some benefits of calorie restriction.
- Stem Cell Activation — Enhances mesenchymal stem cell proliferation and reduces senescence.
- Cellular Rejuvenation — Reverses senescence-associated secretory phenotype in aging cells.
Vesugen FAQ
Does Vesugen activate SIRT1 like calorie restriction and can it be used with fasting?+
Yes, Vesugen regulates SIRT1 (sirtuin 1) protein levels, mimicking some benefits of calorie restriction without requiring dietary restriction. Combining Vesugen with intermittent fasting or calorie restriction could theoretically provide synergistic SIRT1 activation and enhanced anti-aging effects, though this combination hasn't been formally studied.
How does Vesugen prevent atherosclerosis and is it effective for existing plaques?+
Vesugen limits atherosclerosis development by reducing endothelial dysfunction and activating SIRT1 anti-aging pathways in vascular tissue. It's preventive rather than plaque-reversal focused. Early atherosclerosis prevention works better than treating advanced disease, so Vesugen is most valuable as a cardiovascular health maintenance peptide.
Can Vesugen be combined with other Khavinson bioregulators like Epitalon?+
Yes, Vesugen and Epitalon are synergistic in comprehensive anti-aging protocols. Vesugen targets vascular aging while Epitalon addresses pineal/endocrine aging - using them together provides multi-system rejuvenation. They're often combined in Khavinson anti-aging programs with Thymalin or Vilon for enhanced effects.
Does Vesugen reduce senescent cell burden or just prevent new senescence?+
Vesugen reduces senescence markers and reverses the Senescence-Associated Secretory Phenotype (SASP) in aging cells through stem cell activation and epigenetic regulation. This suggests it may reduce existing senescent cells, though the primary mechanism is prevention and restoration rather than elimination of aged cells.
References
Related peptides
Cardiogen
Moderate researchAEDR | Cardiovascular Bioregulator Peptide
Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research.
Epitalon
PreclinicalTetrapeptide studied for telomere & pineal effects
Epitalon is a synthetic tetrapeptide derived from the pineal peptide epithalamin, studied primarily in Russian research for proposed effects on telomerase activity, circadian regulation, and ageing.
Thymalin
Well studiedThymic Peptide Bioregulator | Immune Modulator
Thymalin is a natural peptide bioregulator derived from calf thymus gland, developed in the Soviet Union in the 1970s.
Pinealon
Well studiedSynthetic Tripeptide | Neuroprotection & Cognitive Enhancement
Developed in Russia, Pinealon demonstrates unique DNA-interaction for neuroprotection and cognitive enhancement.
Last reviewed: 2026-06-26. Information is provided for research and educational reference only — see our disclaimer.